Add like
Add dislike
Add to saved papers

Model for end-stage liver disease (MELD) score for predicting late esophageal varices rebleeding in cirrhotic patients.

BACKGROUND/AIMS: Esophageal varices bleeding is a fatal complication of portal hypertension. The model for end-stage liver disease (MELD) has been used as a tool to predict mortality risk in cirrhotic patients. It is currently unknown if MELD score can be applied to predicting late esophageal varices rebleeding. The predictive ability of the MELD score for short-term esophageal varices rebleeding was studied.

METHODOLOGY: Ninety-five cirrhotic patients with esophageal varices bleeding were enrolled with a follow up period of at least 3 months. All patients had undergone a successful hemostasis at admission. Initial admission MELD score and 3-months MELD were obtained to observe their correlation with the late esophageal varices rebleeding.

RESULTS: MELD score of 13 and 16 are the mean MELD score of the admission and 3-months respectively in the rebleeding group. The correlation between initial admission MELD score and late stage data showed a positive linear regression in the rebleeding patients (p=0.001, r=0.773) but not in the non-rebleeding group.

CONCLUSIONS: The MELD score is a good predictor of short term esophageal varices rebleeding rate. At least 2 MELD score data is needed to evaluate the possibilities of rebleeding

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app